News | Cardiovascular Surgery | October 17, 2019

Gore Block Grant Supports SVS Quality Programs

First year funding will focus on programs to improve vascular patient surgical outcomes

Gore Block Grant Supports SVS Quality Programs

October 17, 2019 — W. L. Gore & Associates Inc. will support a new Society for Vascular Surgery (SVS) initiative to advance patient safety programs and the quality of vascular surgical care, the SVS has announced.

Through a general block grant, Gore will help fund SVS quality initiatives designed to improve vascular patient surgical outcomes. These related projects will address key practice factors influencing quality care, including new care delivery and payment models, patient education, costs, surgeon wellness and the value of vascular surgery services. 

First-year funding support will focus on several initiatives, including:

  • Analysis of an advanced payment model that may improve care for patients with peripheral artery disease (PAD);
  • A summit and a call to action for SVS leaders that focused on appropriateness of care;
  • Data analysis of vascular surgeon wellbeing; and
  • Data collection and analysis to address valuation of vascular surgery services.

Gore is committed to two additional years of funding pending progress evaluation of years one and two.  

“At the highest strategic level, SVS and Gore share an important mission goal to improve the quality of lives of vascular patients,” noted SVS Executive Director Kenneth M. Slaw, Ph.D. “This is a new and innovative model that transcends the traditional society/industry relationship and provides an opportunity for SVS and Gore to collaborate more deeply on key quality program initiatives that matter at a mission level.”

For more information: www.gore.com

Related Content

News | Cardiovascular Surgery

November 23, 2021 — A novel device called venous external support (VEST) may lead to increased longevity and durability ...

Home November 23, 2021
Home
News | Cardiovascular Surgery

November 22, 2021 — The Minneapolis Heart Institute Foundation (MHIF) announced the publication of research showing ...

Home November 22, 2021
Home
News | Cardiovascular Surgery

November 18, 2021 — Moderna Inc. announced positive data from the AstraZeneca-led Phase 2 (EPICCURE) study evaluating ...

Home November 18, 2021
Home
News | Cardiovascular Surgery

November 18, 2021 — People who are on the antiplatelet medication ticagrelor and need coronary artery bypass surgery may ...

Home November 18, 2021
Home
Feature | Cardiovascular Surgery | By Noam Emanuel, Ph.D.

Surgical Site Infection (SSI) prevention remains a high priority for cardiac surgeons whose heroic efforts can be ...

Home June 24, 2021
Home
News | Cardiovascular Surgery

April 5, 2021 — Smidt Heart Institute transplant surgeons Dominic Emerson, M.D., and Pedro Catarino, M.D. know how to be ...

Home April 05, 2021
Home
News | Cardiovascular Surgery

March 30, 2020 — Patients undergoing coronary bypass graft (CAGB) surgery lived longer and had better outcomes when ...

Home March 30, 2020
Home
News | Cardiovascular Surgery

February 27, 2020 — The U.S. Food and Drug Administration (FDA) sent a safety communication this week to healthcare to ...

Home February 27, 2020
Home
News | Cardiovascular Surgery

October 23, 2019 — Proactive administration of amiodarone to patients recovering from a common heart surgery shows ...

Home October 23, 2019
Home
News | Cardiovascular Surgery

August 22, 2019 — The amount of opioids prescribed for patients after heart and lung surgery has a direct relationship ...

Home August 22, 2019
Home
Subscribe Now